Consumer Health Information Corp. v. Amylin Pharmaceuticals, Inc.

819 F.3d 992, 118 U.S.P.Q. 2d (BNA) 1361, 2016 U.S. App. LEXIS 6866, 2016 WL 1534013
CourtCourt of Appeals for the Seventh Circuit
DecidedApril 15, 2016
Docket14-3231
StatusPublished
Cited by10 cases

This text of 819 F.3d 992 (Consumer Health Information Corp. v. Amylin Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Consumer Health Information Corp. v. Amylin Pharmaceuticals, Inc., 819 F.3d 992, 118 U.S.P.Q. 2d (BNA) 1361, 2016 U.S. App. LEXIS 6866, 2016 WL 1534013 (7th Cir. 2016).

Opinion

SYKES, Circuit Judge.

Consumer Health Information Corporation sued Amylin Pharmaceuticals, Inc., alleging copyright infringement. . 17 U.S.C. §§ 101 et seq. The dispute centers on copyright ownership: Who owns the copyright in- certain patient-education materials Consumer Health developed for Amylin’s use in marketing its diabetes drug Byetta? The parties’ contract, executed in March 2006, unambiguously assigns the copyright to Amylin. This suit is an attempt to reclaim ownership of the copyright and recover damages for infringement. To that eiid,- Consumer Health alleges that the contract was induced by fraud or economic distress and seeks rescission. The district court dismissed the suit as untimely.

We affirm. Consumer Health assigned the copyright to Amylin in 2006 but did not file this suit until July 2013, several years too late under either of two applicable statutes of limitations. A four-year limitations period applies to claims for contract rescission under California law, which governs the'parties’ contract. Cal.Civ.Proc, Code § 337. Claims under the Copyright Act are subject to a three-year-statute of limitations. 17 U.S.C. § 507(b). Consumer Health’s cause of action accrued in March 2006, when the contract was executed; at that point Consumer Health knew that Amylin owned the copyright, and the limitations clock on a suit to reclaim ownership started ticking. Under either statute of limitations, the suit is untimely.

I. Background

Consumer Health is headquartered in Virginia and promotes itself as having “expertise in patient engagemept and patient adherence strategies,' health literacy, and patient education program development for prescription drugs, over-the-counter *994 products, and medical devices.” Amylin, a large pharmaceutical company, is based in California. Jointly with Eli Lilly & Co., a pharmaceutical giant based in' Indiana, Amylin developed and owns the rights to Byetta, an injectable diabetes drug.

.When Byetta launched in 2005, its initial sales were disappointing, Amylin attributed the slow start to patients not understanding how to properly use the drug and thus declining to refill their prescriptions. An additional problem was that doctors were not adequately trained to demonstrate the use- of Byetta to their patients and so were -reluctant to prescribe it as often as Amylin had projected. So Amylin approached Consumer Health to develop materials that would increase patient education and compliance.

Consumer Health commenced work on the project in December 2005 on the verbal assurance that it would be paid for its services. In March 2006 the parties formalized their arrangement by executing a Master Services Agreement. The contract explicitly assigned to Amylin the copyright in any materials Consumer Health created:

[Consumer Health] hereby assigns to AMYLIN all right, title, and interest in and- to said copyrights in the United States and elsewhere, including registration and publication rights, rights to create derivative works and all other rights which are incident to copyright ownership.

Amylin stopped paying for work after September 30, 2006, but continued to use the materials Consumer Health had developed, or at least certain “constituent elements” of them.

Almost , seven years later, in July 2013, Consumer -Health sued Amylin and Eli Lilly alleging .copyright infringement. 1 The complaint, filed in the Southern District of. Indiana, seeks actual damages and disgorgement of profits attributable to the infringement.. The premise of the suit is that Consumer Health owns the copyright in the educational materials because the contract was induced by fraud or economic duress, either of which is a basis for rescission. More specifically, the complaint alleges that Amylin never intended to fulfill its end of the bargain and that Consumer Health signed the contract under economic duress. The factual premise of the latter contention is that Consumer Health had not yet been paid for its work from December 2005 to March 2006, when it signed the contract, and therefore agreed to the contract only under economic duress. 2

Amylin moved to dismiss the suit as untimely. The district court granted the motion, concluding that the complaint was filed several years too late under either of two applicable statutes of limitations. Under the contract’s choice-of-law provision, the rescission claim is governed by California law, and the California limitations period for rescission claims based on fraud or economic duress is four years. Cal. Civ. ProgCode § 337. The judge held that Consumer Health’s rescission claim accrued in March 2006, when the contract was signed, or at the very latest in October 2006, when Amylin stopped paying for its services. On this accrual analysis, the four-year limitations period expired in ei *995 ther March or October 2010, roughly three years before the suit was filed.

To avoid the time bar, Consumer Health invoked the principle that the statute of limitations does not bar contract defenses and insisted that it was asserting fraud and duress defensively, to block enforcement of the contract. The judge rejected this argument, holding that Consumer Health was using rescission offensively in a suit to recover damages for copyright infringement.

Alternatively,- the judge held that the suit was untimely under the Copyright Act’s three-year statute of limitations. 17 U.S.C., § 507(b). Because the copyright claim;was essentially a dispute over copyright ownership, the judge determined that the claim accrued in March 2006 when the parties signed the contract clearly giving Amylin “all right, title, and interest in and to” the copyright to the educational materials Consumer Health had and would develop. On this accrual analysis, any suit seeking to reclaim copyright ownership had to be filed by March 2009.

To avoid this time bar, Consumer Health urged the court to apply the separate-accrual rule, which holds that each infringing use of copyrighted material triggers a new three-year limitations period. See Petrella v. Metro-Goldwyn-Mayer, Inc., — U.S.-, 134 S.Ct. 1962, 1969, 188 L.Ed.2d 979 (2014). The judge rejected this argument, distinguishing between ordinary infringement cases and cases disputing copyright ownership. Following the Ninth Circuit’s decision in Seven Arts Filmed Entertainment, Ltd. v. Content Media Corp. PLC, 733 F.3d 1251 (9th Cir.2013), the judge held that in the latter category, the cause of action accrues when the ownership dispute becomes explicit. Because this ownership dispute was obvious in March 2006 when the parties executed the Master Services Agreement, the suit was more than four years too late.

II. . Discussion

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
819 F.3d 992, 118 U.S.P.Q. 2d (BNA) 1361, 2016 U.S. App. LEXIS 6866, 2016 WL 1534013, Counsel Stack Legal Research, https://law.counselstack.com/opinion/consumer-health-information-corp-v-amylin-pharmaceuticals-inc-ca7-2016.